JAK2 and breast carcinoma: In addition, a large number of studies have confirmed that JAK2/STAT3 signaling plays an important role in breast cancer progression, regulating key processes including cell proliferation, survival and immune escape (Jiang et al., 2024; Li et al., 2023; Mengie et al., 2022).